End of therapy minimal residual disease (MRD) measurement in children with ALL does not predict relapse
Author(s) -
Tahani Hani Sarrawi,
Ismael Zayyat,
Fareed Barakat,
Maha Rezeq,
Salam Abu Jmaian,
Faris Madanat
Publication year - 2017
Publication title -
hematology/oncology and stem cell therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.666
H-Index - 22
eISSN - 1658-3876
pISSN - 2589-0646
DOI - 10.1016/j.hemonc.2017.05.033
Subject(s) - minimal residual disease , residual , medicine , statistics , oncology , mathematics , algorithm , leukemia
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom